ARA-290 (Cibinetide)

Advanced Cellular Recovery & Tissue Repair Research.

ARA-290 (Cibinetide) is a synthetic peptide derived from erythropoietin (EPO) that has been specifically engineered to target tissue protection and repair without affecting red blood cell production. It has become a promising area of research for its potential role in reducing inflammation, supporting nerve health, and promoting cellular recovery following injury or stress.

Unlike erythropoietin, ARA-290 selectively activates the innate repair receptor (IRR), a receptor involved in the body’s natural healing processes. By stimulating this pathway, researchers have investigated its ability to support tissue regeneration while helping regulate inflammatory responses.

Its unique mechanism of action has made ARA-290 an increasingly studied peptide in research involving nerve health, chronic inflammation, metabolic dysfunction, and tissue recovery.

Research Benefits

• Supports cellular repair and tissue regeneration
• May help regulate inflammatory responses
• Supports peripheral nerve health
• May assist in recovery following tissue injury
• Promotes healthy cellular resilience
• Supports normal healing processes
• Well-studied for its tissue-protective properties
• Research interest in neuropathic conditions and metabolic health